Refine your search
Availability
-
Authors
-
Topics
- Adolescent
- Alemtuzumab
- Antibodies
- Antibodies, Neutralizing
- Biomarkers
- Disease Progression
- Drug Administration Schedule
- Female
- Georgia (Republic)
- Humans
- Immunologic Factors
- Interferon-beta
- Mitoxantrone
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Natalizumab
- Neuroprotective Agents
- Prevalence
- Prognosis
- Recurrence
- Show more
- Show less
-
Languages